Caricamento...
Combination Therapy Using Inhalable GapmeR and Recombinant ACE2 for COVID-19
Here we report our perspective on applying GapmeR technology in combination with recombinant angiotensin-converting enzyme 2 (ACE2) in the treatment of COVID-19 patients. GapmeR is a cell-permeating antisense single-stranded DNA molecule that can be designed to specifically target intracellular seve...
Salvato in:
| Pubblicato in: | Front Mol Biosci |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7427089/ https://ncbi.nlm.nih.gov/pubmed/32850978 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2020.00197 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|